News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | ![]() Neoantigen Targeted Therapies, 2019-2030Roots Analysis is pleased to announce the publication of its recent study, titled, "Neoantigen Targeted Therapies, 2019-2030."
By: Roots Analysis § A detailed assessment of the current market landscape of developers engaged in the development of neoantigen targeted therapies. § Detailed profiles of developers of neoantigen targeted therapies (shortlisted on the basis of the number of pipeline products). § A detailed publication analysis of close to 300 peer-reviewed, scientific articles published during the period 2015-2019 (till February), highlighting the research focus within the industry. § An in-depth analysis of the various patents that have been filed / granted related to neoantigens. § An analysis of the various partnerships pertaining to neoantigen targeting therapies. § An analysis of the investments made at various stages of development in companies that are focused on developing neoantigen targeted therapies. § A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) • Target Disease Indication § Bone and Cartilage Cancer § Colorectal Cancer § Head and Neck Cancer § Renal Carcinoma § Hepatocellular Carcinoma § Lung Cancer § Gynecological Cancer § Others • Type of Treatment § Personalized § Off-the- • Type of Immunotherapy § Dendritic Cell Vaccine § DNA / RNA-based Vaccine § Protein / Peptide-based Vaccine § TIL-based Therapy • Route of Administration § Intradermal § Intravenous § Subcutaneous § Others • Key Geographical Region § North America (US) § Europe (UK, Germany, France, Italy, and Spain § Rest of the World § Transcripts of interviews held with the following senior level representatives of stakeholder companies: Press Release: Variation 1 (Format 2) • Gabriel Nistor, Chief Scientific Officer, AIVITA Biomedical • Ella Sorani, Vice President Research and Development, BioLineRx • Heinz Lubenau, Chief Operating Officer and Co-Founder, VAXIMM Key companies covered in the report (https://www.rootsanalysis.com/ § Bavarian Nordic § Genocea Biosciences § Gradalis § Immunicum § Immunovative Therapies § Iovance Biotherapeutics § Medigene § Neon Therapeutics § Precision Biologics § Vaxon Biotech For more information please click on the following link: https://www.rootsanalysis.com/ Other Recent Offerings 1. T-Cell Immunotherapies Market (4th Edition), 2019-2030 (https://www.rootsanalysis.com/ 2. Novel Immuno-Oncology Biomarker Testing Market, 2019-2030 3. Companion Diagnostics Market (2nd Edition), 2019-2030 Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 Gaurav.Chaudhary@ End
|
|